Bibliografia UJ CM



Zapytanie: GIERCZYNSKI J
Liczba odnalezionych rekordów: 6



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wersja do druku | | | Nowe wyszukiwanie
1/6
P[aweł] Kawalec, J. Gierczynski, J. Lis, M. Glasek.
Budget impact analysis of reimbursement of aravaŽ (leflunomide) in the treatment of rheumatoid arthritis in Poland.
Value in Health
2009 : Vol. 12, nr 7, s. A436
ISPOR Twelfth Annual European Congress, Paris, France, October 24-27, 2009.
SZZ
SIF
2/6
P. McEwan, A. Woehl, P[aweł] Kawalec, J. Lis, J. Gierczynski, J. Walczak.
Cost-utility of insulin glargine compared to NPH in type DMI from a public payer perspective in Poland.
Value in Health
2008 : Vol. 11, nr 6, s. A508, abstr. PDB40
ISPOR Eleventh Annual European Congress, Athens, Greece, November 8-11, 2008.
SZZ
SIF
3/6
P. McEwan, A. Woehl, P[aweł] Kawalec, J. Lis, J. Gierczynski, J. Walczak.
Cost-utility of insulin glargine compared to premix in type 2 from public payer perspective in Poland.
Value in Health
2008 : Vol. 11, nr 6, s. A509, abstr. PDB42
ISPOR Eleventh Annual European Congress, Athens, Greece, November 8-11, 2008.
SZZ
SIF
4/6
P. McEwan, A. Woehl, P[aweł] Kawalec, J. Lis, J. Gierczynski, J. Walczak.
Is insulin glargine a cost-effective option for treatment of patients naive to insulin treatment with type 2, baseline HBA 1C above 8% and age below 65 years in comparison to NPH and premix in Poland.
Value in Health
2008 : Vol. 11, nr 6, s. A507, abstr. PDB37
ISPOR Eleventh Annual European Congress, Athens, Greece, November 8-11, 2008.
SZZ
SIF
5/6
P. McEwan, A. Woehl, P[aweł] Kawalec, J. Lis, J. Gierczynski, J. Walczak.
Is insulin glargine a cost-effective option in treatment of patients with DMI with baseline HBAC above 8% in comparison to NPH and premix in Poland?
Value in Health
2008 : Vol. 11, nr 6, s. A508, abstr. PDB39
ISPOR Eleventh Annual European Congress, Athens, Greece, November 8-11, 2008.
SZZ
SIF
6/6
P[aweł] Kawalec, J. Lis, J. Gierczynski.
Cost of community acquired pneumonia (CAP) treatment with Ketek (telithromycin) vs clarithromycin from public payer perspective in Poland.
Value in Health
2005 : Vol. 8, nr 6, s. A214, abstr. PRS9
ISPOR Eighth Annual European Congress, Florence, Italy, November 6-8, 2005.
SZZ
SIF
  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ